##plugins.themes.academic_pro.article.sidebar##
Main Article Content
Abstract
Background: Tumor lysis syndrome is metabolic abnormalities due to accumulation of intracellular contents in systemic circulation. Cairo and Bishop criteria is used to diagnosing it. Patient with hematological malignancies such as acute leukemia is more prone to this syndrome, and also infection that comes with it. Evaluating tumor lysis syndrome, especially knowing which laboratory parameters used and probable complication are crucial.
Case Report: Two years old boy undergone maintenance chemotherapy for his ALL L2 that has been diagnosed one year ago. Patient has no complaint at admission, but went to worsened condition as the chemotherapy was given. Electrolyte imbalances and clinical manifestations depicting tumor lysis syndrome was found. Patient also experiencing pneumonia, gastrointestinal tract infection and sepsis (PELOD score 15).
Conclusion and Suggestion: Patient experiencing tumor lysis syndrome when he was going through maintenance chemotherapy. Even though he was admitted without any major complaints, but hyperuricemia and elevated creatinine at the time of admission should be considered before initiating chemotherapy. Sepsis in this patient might be cause by bacterial infection of the gastrointestinal tract due to his severe neutropenia condition.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
2. Howard, S. C., Jones, D. P. & Pui, C.-H. The Tumor Lysis Syndrome. N. Engl. J. Med. 364, 1844–1854 (2011).
3. Cairo, M. S. & Bishop, M. Tumour lysis syndrome: new therapeutic strategies and classification: New Therapeutic Strategies and Classification of TLS. Br. J. Haematol. 127, 3–11 (2004).
4. Brown, P. et al. Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. 18, 81–112 (2020).
5. Inaba, H. et al. Infection-related complications during treatment for childhood acute lymphoblastic leukemia. Ann. Oncol. 28, 386–392 (2017).
6. Bain, B. J. & Estcourt, L. FAB Classification of Leukemia. in Brenner’s Encyclopedia of Genetics 5–7 (Elsevier, 2013). doi:10.1016/B978-0-12-374984-0.00515-5.
7. Labati, R. D., Piuri, V. & Scotti, F. All-IDB: The acute lymphoblastic leukemia image database for image processing. in 2011 18th IEEE International Conference on Image Processing 2045–2048 (IEEE, 2011). doi:10.1109/ICIP.2011.6115881.
8. Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391–2405 (2016).
9. Keohane, E. M., Smith, L. J. & Walenga, J. M. Rodak’s Hematology: Clinical Principles and Applications. (Elsevier Inc., 2016).
10. Kaplan, L. A., Pesce, A. J. & Steven C. Clinical Chemistry: Theory, Analysis, Correlation. Clin. Chem. (2010) doi:10.1373/clinchem.2003.017731.
11. Mirrakhimov, A. E. Hypercalcemia of Malignancy: An Update on Pathogenesis and Management. North Am. J. Med. Sci. 7, 483–493 (2015).
12. Martins, A. L. et al. Severe hypercalcemia as a form of acute lymphoblastic leukemia presentation in children. Rev. Bras. Ter. Intensiva 27, 402–405 (2015).
13. Marinella, M. A. Refeeding Syndrome and Hypophosphatemia. J. Intensive Care Med. 20, 155–159 (2005).
14. Nagai, A. et al. Hyperuricemia in Pediatric Malignancies Before Treatment. Nucleosides Nucleotides Nucleic Acids 30, 1060–1065 (2011).
15. Rusu, R.-A. et al. Chemotherapy-related infectious complications in patients with Hematologic malignancies. J. Res. Med. Sci. Off. J. Isfahan Univ. Med. Sci. 23, 68 (2018).
16. Punnapuzha, S., Edemobi, P. K. & Elmoheen, A. Febrile Neutropenia. in StatPearls (StatPearls Publishing, 2021